Source: PR-INSIDE.COM

Press Release: Esperance : Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014 By Radiant Insights

(PR-inside.com) Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Esperance Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Esperance Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. View summary of this report, click the link below: http://www.radiantinsights.com/research/esperance-pharmaceuticals-inc-product-pipeline-review-2014 Global ..

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Esperancepharma yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Hector Alila's photo - President & CEO of Esperancepharma

President & CEO

Hector Alila

CEO Approval Rating

68/100

Esperance is a clinical stage company, that develops targeted anticancer drugs. Read more